Rethinking Psychedelics

Once firmly rooted in the countercultural movement, psychedelics are now being re-examined through the lens of science, wellness, and creativity. No longer defined solely by their 1970s reputation, these substances are gaining renewed attention for their potential therapeutic applications — particularly in the treatment of conditions such as depression and PTSD. Clinical psychologist Dr. Saliha Afridi and psychedelic researcher and co-founder of Arab Psychedelic Society Noor Ramadhan will guide an exploration into this evolving field, touching on their neurological impact, ethical and legal considerations, the emergence of guided retreats, and their growing relevance to artists, innovators, and researchers alike.